Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Homeodent is a phytopharmaceutical mouthwash preparation developed by Boiron, primarily evaluated for the prevention and treatment of oral mucositis in patients undergoing radiotherapy for head and neck cancers. It is a botanical-based formulation typically containing extracts such as *Calendula officinalis*, *Hamamelis virginiana*, *Plantago major*, and *Cochlearia armoracia*. These ingredients are traditionally used for their anti-inflammatory, antiseptic, and healing properties. In clinical trials, it has been compared against standard care (such as sodium bicarbonate mouthwash) to assess its efficacy in reducing the incidence of severe (Grade 3 or higher) radiation-induced oral mucositis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Homeodent.